Orphan drug incentives in the pharmacogenomic context: policy responses in the US and Canada

Advances in pharmacogenomic research and increasing industry interest in personalized medicine have important implications for the way that orphan drug policies are interpreted and applied. Concerns have been raised about the potential impact of pharmacogenomics and new genomic technologies on our u...

Descripción completa

Detalles Bibliográficos
Autores principales: Gibson, Shannon, von Tigerstrom, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034370/
https://www.ncbi.nlm.nih.gov/pubmed/27774196
http://dx.doi.org/10.1093/jlb/lsv013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034370/
https://www.ncbi.nlm.nih.gov/pubmed/27774196
http://dx.doi.org/10.1093/jlb/lsv013

Ejemplares similares